Chronic inflammation is characteristic of T2D, and inflammation is a risk factor for inducing muscle atrophy by upregulating the levels of muscle atrophy-related factors, such as atrogin-1 and MuRF-1 [6,29]. Here, FBXO32 is linked to type 2 diabetes mellitus.